NCT Number: NCT05345444
Phase: Not Applicable
Trial Summary: This is a single-site trial for 42 subjects with intermediate risk prostate cancer who undergo Irreversible Electroporation (IRE) followed by Magnetic Resonance guided Radiotherapy – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Weill Medical College of Cornell University
Acronym: RTIRE
Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives